Small Molecule Publications

Acknowledging ICCB-L in Publications

Researchers using the services of ICCB-L staff or equipment agree to acknowledge the support of 'ICCB-Longwood Screening Facility at Harvard Medical School' in publications arising from your use of the facility. If an ICCB-L member has made an important intellectual contribution to the project, as determined by generally accepted criteria for academic collaborations, then that person should be considered for authorship on the publication. If your project was supported by a grant that also directly supports the ICCB-L, please consult the ICCB-L Director regarding the appropriate grant citation. Please notify Jen Smith upon public release of your publication.

Below is a list of publications that have resulted from small molecule screening efforts at ICCB-Longwood. Please notify us of your publications that involve use of the ICCB-Longwood Screening Facility.

2026

Petrova V, Mills CE, Hug C, Cetinkaya-Fisgin A, Splaine J, Fouladzadeh S, Hakim S, Powell R, Zhen S, Chung M, Bradshaw GA, Deng T, Singec I, Wang Q, Kawaguchi R, Jonnagaddala H, Barrett LB, Smith JA, Kalocsay M, Gyori BM, Hoke A, Sorger PK, Woolf CJ. A human iPSC-derived sensory neuron platform for high-throughput discovery of neuroprotectants against chemotherapy-induced peripheral neuropathy.
Cell Reports Medicine. Elsevier; 2026;
Petrova V, Mills CE, Hug C, Cetinkaya-Fisgin A, Splaine J, Fouladzadeh S, Hakim S, Powell R, Zhen S, Chung M, Bradshaw GA, Deng T, Singec I, Wang Q, Kawaguchi R, Jonnagaddala H, Barrett LB, Smith JA, Kalocsay M, Gyori BM, Hoke A, Sorger PK, Woolf CJ. A human iPSC-derived sensory neuron platform for high-throughput discovery of neuroprotectants against chemotherapy-induced peripheral neuropathy.
Cell Reports Medicine. Elsevier; 2026;

2025

Law JD, Gao Y, Kovvali S, Thirugnanasambantham P, Wysocki VH, Ahmer BMM, Gopalan V. Identification of inhibitors of the Salmonella FraB deglycase, a drug target.
FEBS open bio. 2025; PMID: 39945759
Law JD, Gao Y, Kovvali S, Thirugnanasambantham P, Wysocki VH, Ahmer BMM, Gopalan V. Identification of inhibitors of the Salmonella FraB deglycase, a drug target.
FEBS open bio. 2025; PMID: 39945759
Quek RT, Shirazinejad CR, Young CL, Hardy KS, Lim S, Elms PJ, McSwiggen DT, Mitchison TJ, Silver PA. Comparative evaluation of cell-based assay technologies for scoring drug-induced condensation of SARS-CoV-2 nucleocapsid protein.
SLAS discovery : advancing life sciences R & D. 2025;31:100220. PMID: 39894078
Quek RT, Shirazinejad CR, Young CL, Hardy KS, Lim S, Elms PJ, McSwiggen DT, Mitchison TJ, Silver PA. Comparative evaluation of cell-based assay technologies for scoring drug-induced condensation of SARS-CoV-2 nucleocapsid protein.
SLAS discovery : advancing life sciences R & D. 2025;31:100220. PMID: 39894078
SLAS discovery : advancing life sciences R & D. 2025;32:100221. PMID: 39947627
SLAS discovery : advancing life sciences R & D. 2025;32:100221. PMID: 39947627

2024

Niu X, Melendez DL, Raj S, Cai J, Senadeera D, Mandelbaum J, Shestopalov IA, Martin SD, Zon LI, Schlaeger TM, Lai LP, McMahon AP, Craft AM, Galloway JL. A conserved transcription factor regulatory program promotes tendon fate.
Developmental cell. 2024;59(23):3106–3123.e12. PMID: 39216481
Niu X, Melendez DL, Raj S, Cai J, Senadeera D, Mandelbaum J, Shestopalov IA, Martin SD, Zon LI, Schlaeger TM, Lai LP, McMahon AP, Craft AM, Galloway JL. A conserved transcription factor regulatory program promotes tendon fate.
Developmental cell. 2024;59(23):3106–3123.e12. PMID: 39216481
ACS infectious diseases. 2024; PMID: 39741382
ACS infectious diseases. 2024; PMID: 39741382
Journal of the American Chemical Society. 2024;146(38):26320–26330. PMCID: PMC11440498
Journal of the American Chemical Society. 2024;146(38):26320–26330. PMCID: PMC11440498
Petrova V, Snavely AR, Splaine J, Zhen S, Singh B, Pandey R, Chen K, Cheng A, Hermawan C, Barrett LB, Smith JA, Woolf CJ. Identification of novel neuroprotectants against vincristine-induced neurotoxicity in iPSC-derived neurons.
Cellular and molecular life sciences : CMLS. 2024;81(1):315. PMCID: 11335239
Petrova V, Snavely AR, Splaine J, Zhen S, Singh B, Pandey R, Chen K, Cheng A, Hermawan C, Barrett LB, Smith JA, Woolf CJ. Identification of novel neuroprotectants against vincristine-induced neurotoxicity in iPSC-derived neurons.
Cellular and molecular life sciences : CMLS. 2024;81(1):315. PMCID: 11335239
Shehadeh F, Felix L, Kalligeros M, Shehadeh A, Fuchs BB, Ausubel FM, Sotiriadis PP, Mylonakis E. Machine learning-assisted high-throughput screening for Anti-MRSA compounds.
IEEE/ACM transactions on computational biology and bioinformatics. 2024;PP. PMID: 39058605
Shehadeh F, Felix L, Kalligeros M, Shehadeh A, Fuchs BB, Ausubel FM, Sotiriadis PP, Mylonakis E. Machine learning-assisted high-throughput screening for Anti-MRSA compounds.
IEEE/ACM transactions on computational biology and bioinformatics. 2024;PP. PMID: 39058605
Rawat V, DeLear P, Prashanth P, Ozgurses ME, Tebeje A, Burns PA, Conger KO, Solís C, Hasnain Y, Novikova A, Endress JE, González-Sánchez P, Dong W, Stephanopoulos G, DeNicola GM, Harris IS, Sept D, Mason FM, Coloff JL. Drug screening in human physiologic medium identifies uric acid as an inhibitor of rigosertib efficacy.
JCI insight. 2024;9(13). PMID: 38815134
Rawat V, DeLear P, Prashanth P, Ozgurses ME, Tebeje A, Burns PA, Conger KO, Solís C, Hasnain Y, Novikova A, Endress JE, González-Sánchez P, Dong W, Stephanopoulos G, DeNicola GM, Harris IS, Sept D, Mason FM, Coloff JL. Drug screening in human physiologic medium identifies uric acid as an inhibitor of rigosertib efficacy.
JCI insight. 2024;9(13). PMID: 38815134
Chen Y, Chaudhari S, Harris D, Roberts C, Moscalu A, Mathur V, Zhao L, Tavakkoli, Devlin A, Sheu E. A small intestinal bile acid modulates the gut microbiome to improve host metabolic phenotypes following bariatric surgery.
Cell Host Microbe. 2024;17.
Chen Y, Chaudhari S, Harris D, Roberts C, Moscalu A, Mathur V, Zhao L, Tavakkoli, Devlin A, Sheu E. A small intestinal bile acid modulates the gut microbiome to improve host metabolic phenotypes following bariatric surgery.
Cell Host Microbe. 2024;17.
Do B, Hsu P, Vermeulen S, Wang Z, Hirz T, Abbott K, Aziz N, Replogle J, Bjelosevic S, Paolino J, Nelson S, Block S, Darnell A, Ferreira R, Zhang, Milosevic J, Schmidt D, Chidley C, Harris I, Weissman J, Pikman Y, Stegmaier K, Cheloufi S, Su X, Syke D, Vander-Heiden M. Nucleotide depletion promotes cell fate transitions by inducing DNA replication stress.
Dev Cell. 2024;May.
Do B, Hsu P, Vermeulen S, Wang Z, Hirz T, Abbott K, Aziz N, Replogle J, Bjelosevic S, Paolino J, Nelson S, Block S, Darnell A, Ferreira R, Zhang, Milosevic J, Schmidt D, Chidley C, Harris I, Weissman J, Pikman Y, Stegmaier K, Cheloufi S, Su X, Syke D, Vander-Heiden M. Nucleotide depletion promotes cell fate transitions by inducing DNA replication stress.
Dev Cell. 2024;May.
Elfawal M, Goetz E, Kim Y, Chen P, Savinov S, Barasa L, Thompson P, Aroian R. High-Throughput Screening of More Than 30,000 Compounds for Anthelmintics against Gastrointestinal Nematode Parasites.
ACS Infect Dis. 2024;(Dec 9). PMID: 39653369
Elfawal M, Goetz E, Kim Y, Chen P, Savinov S, Barasa L, Thompson P, Aroian R. High-Throughput Screening of More Than 30,000 Compounds for Anthelmintics against Gastrointestinal Nematode Parasites.
ACS Infect Dis. 2024;(Dec 9). PMID: 39653369
Fontana P, Du G, Zhang Y, Zhang H, Vora S, Hu J, Shi M, Tufan A, Healy L, Xia S, Lee DJ, Li Z, Baldominos P, Ru H, Luo H, Agudo J, Lieberman J, Wu H. Small-molecule GSDMD agonism in tumors stimulates antitumor immunity without toxicity.
Cell. 2024;187(22):6165–6181. PMID: 39243763
Fontana P, Du G, Zhang Y, Zhang H, Vora S, Hu J, Shi M, Tufan A, Healy L, Xia S, Lee DJ, Li Z, Baldominos P, Ru H, Luo H, Agudo J, Lieberman J, Wu H. Small-molecule GSDMD agonism in tumors stimulates antitumor immunity without toxicity.
Cell. 2024;187(22):6165–6181. PMID: 39243763
Saffari A, Brechmann B, Böger C, Saber W, Jumo H, Whye D, Wood D, Wahlster L, Alecu J, Ziegler M, Scheffold M, Winden K, Hubbs J, Buttermore E, Barrett, Borner G, Davies A, Ebrahimi-Fakhari D, Sahin M. High-content screening identifies a small molecule that restores AP-4-dependent protein trafficking in neuronal models of AP-4-associated hereditary spastic paraplegia.
Nat Commun. 2024;15(1):584.
Saffari A, Brechmann B, Böger C, Saber W, Jumo H, Whye D, Wood D, Wahlster L, Alecu J, Ziegler M, Scheffold M, Winden K, Hubbs J, Buttermore E, Barrett, Borner G, Davies A, Ebrahimi-Fakhari D, Sahin M. High-content screening identifies a small molecule that restores AP-4-dependent protein trafficking in neuronal models of AP-4-associated hereditary spastic paraplegia.
Nat Commun. 2024;15(1):584.
Issa H, Fléchon L, Laine W, Ouelkdite A, Gaggero S, Cozzani A, Tilmont R, Chauvet P, Gower N, Sklavenitis-Pistofidis R, Brinster C, Thuru X, Touil Y, Quesnel B, Mitra S, Ghobrial I, Kluza J, Manier S. MYC dependency in GLS1 and NAMPT is a therapeutic vulnerability in multiple myeloma.
iScience. 2024;27(4):109417.
Issa H, Fléchon L, Laine W, Ouelkdite A, Gaggero S, Cozzani A, Tilmont R, Chauvet P, Gower N, Sklavenitis-Pistofidis R, Brinster C, Thuru X, Touil Y, Quesnel B, Mitra S, Ghobrial I, Kluza J, Manier S. MYC dependency in GLS1 and NAMPT is a therapeutic vulnerability in multiple myeloma.
iScience. 2024;27(4):109417.
Front. Microbiol. 2024;(16 April). PMCID: PMC11061419
Front. Microbiol. 2024;(16 April). PMCID: PMC11061419
Soni D, Borriello F, Scott D, Feru F, DeLeon M, Brightman S, Cheng W, Melhem G, Smith J, Ramirez J, Barman S, Cameron M, Kelly A, Walker K, Nanishi E, vanHaren S, Phan T, Qi Y, Kinsey R, Raczy M, Ozonoff A, Pettengill M, Hubbell J, Fox C, Dowling D, Levy O. From hit to vial: Precision discovery and development of an imidazopyrimidine TLR7/8 agonist adjuvant formulation.
Sci Adv. 2024;10(27):eadg3747.
Soni D, Borriello F, Scott D, Feru F, DeLeon M, Brightman S, Cheng W, Melhem G, Smith J, Ramirez J, Barman S, Cameron M, Kelly A, Walker K, Nanishi E, vanHaren S, Phan T, Qi Y, Kinsey R, Raczy M, Ozonoff A, Pettengill M, Hubbell J, Fox C, Dowling D, Levy O. From hit to vial: Precision discovery and development of an imidazopyrimidine TLR7/8 agonist adjuvant formulation.
Sci Adv. 2024;10(27):eadg3747.

2023

Sabag-Daigle A, Boulanger E, Thirugnanasambantham P, Law J, Bogard A, Behrman E, Gopalan V, Ahmer B. Identification of Small-Molecule Inhibitors of the Salmonella FraB Deglycase Using a Live-Cell Assay.
Microbiol Spectr. 2023;11(2):e0460622.
Sabag-Daigle A, Boulanger E, Thirugnanasambantham P, Law J, Bogard A, Behrman E, Gopalan V, Ahmer B. Identification of Small-Molecule Inhibitors of the Salmonella FraB Deglycase Using a Live-Cell Assay.
Microbiol Spectr. 2023;11(2):e0460622.
Lin, Chen DY, Scartelli C, Xie H, Merrill-Skoloff G, Yang M, Sun, Saeed M, Flaumenhaft. Plant flavonoid inhibition of SARS-CoV-2 main protease and viral replication.
iScience. 2023;26(9):107602.
Lin, Chen DY, Scartelli C, Xie H, Merrill-Skoloff G, Yang M, Sun, Saeed M, Flaumenhaft. Plant flavonoid inhibition of SARS-CoV-2 main protease and viral replication.
iScience. 2023;26(9):107602.
Sadeeshkumar H, Balaji A, Sutherland A, Mootien, Anthony K, Breaker R. Screening for small molecule inhibitors of SAH nucleosidase using an SAH riboswitch.
Anal Biochem. 2023;666:115047.
Sadeeshkumar H, Balaji A, Sutherland A, Mootien, Anthony K, Breaker R. Screening for small molecule inhibitors of SAH nucleosidase using an SAH riboswitch.
Anal Biochem. 2023;666:115047.
Abbott K, Ali A, Casalena D, Do B, Ferreira R, Cheah J, Soule C, Deik A, Kunchok T, Schmidt D, Renner S, Honeder S, Wu M, Chan S, Tseyang T, Stoltzfus A, Michel S, Greaves D, Hsu P, Ng C, Zhang C, Farsidjani A, Kent J, Madariaga M, Gramatikov M, Matheson N, Lewis C, Clish C, Rees M, Roth J, Griner L, Muir A, Auld D, Heiden M. Screening in serum-derived medium reveals differential response to compounds targeting metabolism.
Cell Chem Biol. 2023;30(9):1156–1168.
Abbott K, Ali A, Casalena D, Do B, Ferreira R, Cheah J, Soule C, Deik A, Kunchok T, Schmidt D, Renner S, Honeder S, Wu M, Chan S, Tseyang T, Stoltzfus A, Michel S, Greaves D, Hsu P, Ng C, Zhang C, Farsidjani A, Kent J, Madariaga M, Gramatikov M, Matheson N, Lewis C, Clish C, Rees M, Roth J, Griner L, Muir A, Auld D, Heiden M. Screening in serum-derived medium reveals differential response to compounds targeting metabolism.
Cell Chem Biol. 2023;30(9):1156–1168.
Front. Antibiot. 2023;2(21 August 2023).
Front. Antibiot. 2023;2(21 August 2023).
Angew Chem Int Ed Engl. 2023;62(25):e202301522.
Angew Chem Int Ed Engl. 2023;62(25):e202301522.
Zhao J, DiGiacomo V, Ferreras-Gutierrez M, Dastjerdi S, deOpakua A, Park JC, Luebbers A, Chen Q, Beeler A, Blanco F, Garcia-Marcos M. Small-molecule targeting of GPCR-independent noncanonical G-protein signaling in cancer.
Proc Natl Acad Sci U S A. 2023;120(18):e2213140120.
Zhao J, DiGiacomo V, Ferreras-Gutierrez M, Dastjerdi S, deOpakua A, Park JC, Luebbers A, Chen Q, Beeler A, Blanco F, Garcia-Marcos M. Small-molecule targeting of GPCR-independent noncanonical G-protein signaling in cancer.
Proc Natl Acad Sci U S A. 2023;120(18):e2213140120.
Chen, Lye M, Gorgulla C, Ficarro S, Cuny G, Scott D, Wu F, Rothlauf P, Wang, Fernandez R, Pesola J, Draga S, Marto J, Hogle J, Arthanari, Coen D. A small molecule exerts selective antiviral activity by targeting the human cytomegalovirus nuclear egress complex.
PLoS Pathog. 2023;19(11):e1011781.
Chen, Lye M, Gorgulla C, Ficarro S, Cuny G, Scott D, Wu F, Rothlauf P, Wang, Fernandez R, Pesola J, Draga S, Marto J, Hogle J, Arthanari, Coen D. A small molecule exerts selective antiviral activity by targeting the human cytomegalovirus nuclear egress complex.
PLoS Pathog. 2023;19(11):e1011781.
Ajay A, Chu P, Patel P, Deban C, Roychowdhury C, Heda R, Halawi A, Saad A, Younis N, Zhang, Jiang X, Nasr M, Hsiao LL, Lin G, Azzi J. High-Throughput/High Content Imaging Screen Identifies Novel Small Molecule Inhibitors and Immunoproteasomes as Therapeutic Targets for Chordoma.
Pharmaceutics. 2023;15(4):1274.
Ajay A, Chu P, Patel P, Deban C, Roychowdhury C, Heda R, Halawi A, Saad A, Younis N, Zhang, Jiang X, Nasr M, Hsiao LL, Lin G, Azzi J. High-Throughput/High Content Imaging Screen Identifies Novel Small Molecule Inhibitors and Immunoproteasomes as Therapeutic Targets for Chordoma.
Pharmaceutics. 2023;15(4):1274.